VP
Vinitha Perumandla
About Vinitha Perumandla
Data last updated:
Vinitha Perumandla has 2 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Clarsun Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Clarsun Pharmaceuticals Private Limited at ₹36.3 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Clarsun Pharmaceuticals Private Limited U24303TG2022PTC159485 | Additional Director | 17 Apr 2024 | 2022 | ₹36.3 Lakh (FY 2024) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Vinitha Perumandla
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vinitha Perumandla
Vinitha Perumandla has 2 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Clarsun Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Clarsun Pharmaceuticals Private Limited at ₹36.3 Lakh (FY 2024).
Vinitha Perumandla is associated with 1 company as Additional Director, including Clarsun Pharmaceuticals Private Limited (₹36.3 Lakh).
Vinitha Perumandla has expertise in General Business.
Vinitha Perumandla has 2 years in corporate governance.
By reported revenue, the largest current company of Vinitha Perumandla is Clarsun Pharmaceuticals Private Limited, with revenue of ₹36.3 Lakh (FY 2024).
Vinitha Perumandla currently holds positions at 1 company: Clarsun Pharmaceuticals Private Limited (₹36.3 Lakh).